Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

ATRA holding history

Atara Biotherapeutics, Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ATRA overviewAll 13F holders of ATRAFull Q2 2026 holdings

Shares (Q2 2026)
441,701
Value
$5.07M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ATRA by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026441,701$5.07M0.3%00.0%UnchangedHolders
Q1 2026441,701$2.09M0.1%00.0%UnchangedHolders
Q4 2025441,701$7.99M0.6%00.0%UnchangedHolders
Q3 2025441,701$6.33M0.6%00.0%UnchangedHolders
Q2 2025441,701$3.41M0.4%00.0%UnchangedHolders
Q1 2025441,701$2.62M0.2%00.0%UnchangedHolders
Q4 2024441,701$5.88M0.4%−10,569−2.3%ReducedHolders
Q3 2024452,270$3.68M0.2%00.0%UnchangedHolders
Q2 2024452,270$3.84M0.2%+81,738+22.1%AddedConverted for a 1-for-25 splitHolders
Q1 20249,263,309$6.43M0.2%+156,863+1.7%AddedHolders
Q4 20239,106,446$4.67M0.2%+2,825,633+45.0%AddedHolders
Q3 20236,280,813$9.30M0.4%+232,690+3.8%AddedHolders
Q2 20236,048,123$9.74M0.4%+436,067+7.8%AddedHolders
Q1 20235,612,056$16.3M0.7%−630,700−10.1%ReducedHolders
Q4 20226,242,756$20.5M0.8%00.0%UnchangedHolders
Q3 20226,242,756$23.6M0.9%00.0%UnchangedHolders
Q2 20226,242,756$48.6M1.9%−3,155−0.1%ReducedHolders
Q1 20226,245,911$58.0M1.8%−191,866−3.0%ReducedHolders
Q4 20216,437,777$101.5M2.3%−28,500−0.4%ReducedHolders
Q3 20216,466,277$115.7M2.0%+16,700+0.3%AddedHolders
Q2 20216,449,577$100.3M1.5%−435,656−6.3%ReducedHolders
Q1 20216,885,233$98.9M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.